Slide background

Slide background
Slide background
Slide background

Loading Events
November
2018
6
New York Cancer Genomics Research Network Meeting

5:00 PM — 8:00 PM

Moderated by Harold Varmus, MD

See New York Genome Center’s lecture series, events and archives VIEW FULL CALENDAR

About

 

 

 

To advance collaborative efforts on cancer genomics, the New York Genome Center (NYGC) hosts meetings on the first Tuesday of every month to bring together leading cancer researchers, clinicians and postdocs from the NYGC’s Institutional Founding Members and other key academic institutions. The organizers include Drs. Harold Varmus (NYGC & Weill Cornell Medicine), Marcin Imielinski (NYGC &Weill Cornell Medicine), Ross Levine (Memorial Sloan Kettering Cancer Center) and Sohail Tavazoie (The Rockefeller University). 

 

Norman (Ned) Sharpless, the recently appointed Director of the National Cancer Institute (NCI), will conclude his visit to the NYGC by speaking at 5PM about his experiences at the NCI thus far and his future plans.

 

Since the cancer research community in New York City is heavily dependent on NCI policies, activities, and funding, this will be an important event. In addition, Dr. Sharpless will be followed by Professor Simon Tavaré, who has recently arrived in New York from Cambridge University to direct programs that include computational approaches to cancer genomics at Columbia University and the NYGC.

 

We urge you and colleagues at all career phases to attend this exciting and informative session.

 

WHEN:
Tuesday, November 6, 2018
5:00 PM – 7:00 PM: Speaker Presentations and Q&A
7:00 PM – 8:00 PM: Hors d’oeuvres & Networking

 

WHERE:
New York Genome Center
101 Avenue of the Americas, 1st Floor Auditorium

 

REGISTER

 

 

 

MODERATOR

Harold Varmus, MD 

Senior Associate Core Member
New York Genome Center

 

 

Lewis Thomas University Professor of Medicine
Weill Cornell Medicine

 

 

 

 

 

 

 

 

SPEAKERS

 

Norman Sharpless, MD
Director
National Cancer Institute

 

“Data Science and Cancer Care”

 

Norman E. “Ned” Sharpless, M.D., was officially sworn in as the 15th director of the National Cancer Institute (NCI) on October 17, 2017. Prior to his appointment, Dr. Sharpless served as the director of the University of North Carolina (UNC) Lineberger Comprehensive Cancer Center, a position he held since January 2014.

 

Dr. Sharpless was a Morehead Scholar at UNC–Chapel Hill and received his undergraduate degree in mathematics. He went on to pursue his medical degree from the UNC School of Medicine, graduating with honors and distinction in 1993. He then completed his internal medicine residency at the Massachusetts General Hospital and a hematology/oncology fellowship at Dana-Farber/Partners Cancer Care, both of Harvard Medical School in Boston.

 

After 2 years on the faculty at Harvard Medical School, he joined the faculty of the UNC School of Medicine in the Departments of Medicine and Genetics in 2002. He became the Wellcome Professor of Cancer Research at UNC in 2012.

 

Dr. Sharpless is a member of the Association of American Physicians as well as the American Society for Clinical Investigation (ASCI), the nation’s oldest honor society for physician–scientists, and served on the ASCI council from 2011 to 2014. Dr. Sharpless was an associate editor of Aging Cell and deputy editor of the Journal of Clinical Investigation. He has authored more than 150 original scientific papers, reviews, and book chapters, and is an inventor on 10 patents. He cofounded two clinical-stage biotechnology companies: G1 Therapeutics and HealthSpan Diagnostics.

 

In addition to serving as Director of NCI, Dr. Sharpless continues his research in understanding the biology of the aging process that promotes the conversion of normal self-renewing cells into dysfunctional cancer cells. Dr. Sharpless has made seminal contributions to the understanding of the relationship between aging and cancer, and in the preclinical development of novel therapeutics for melanoma, lung cancer, and breast cancer.

 

To learn more about Dr. Sharpless’ research, visit his profile page.

 

 

Simon Tavaré, PhD

Senior Associate Core Member
New York Genome Center

 

Director, Irving Institute for Cancer Dynamics
Departments of Statistics and Biological Sciences
Columbia University

 

“Computational Cancer Genomics at NYGC and Beyond”

 

Simon Tavaré, PhD, is a Senior Associate Core Member at the New York Genome Center (NYGC).  Dr. Tavaré, one of the world’s experts in statistics and probability in computational biology, became Founding Director of the Herbert and Florence Irving Institute of Cancer Dynamics at Columbia University in July 2018. He also holds appointments at Columbia in the departments of Statistics and Biological Sciences and as a member of the Herbert Irving Comprehensive Cancer Center.

 

Prior to joining Columbia, Dr. Tavaré was Director of the Cancer Research UK Cambridge Institute, and Professor in the Departments of Oncology and Applied Mathematics and Theoretical Physics at the University of Cambridge.

 

His research interests include statistical genetics, evolutionary approaches to cancer and stochastic computation. Dr. Tavaré forges connections and collaborations between the NYGC and other cancer research centers around the world, including leading a community-wide working group to build collaborations in cancer analytics.

 

He spent 25 years in academia in the United States before moving to Cambridge in 2004. He was elected as a Fellow of the Academy of Medical Sciences and in 2011 as a Fellow of the Royal Society. He currently serves as President of the London Mathematical Society. Dr. Tavaré received his BSc degree, MSc degree and PhD in Probability and Statistics from the University of Sheffield, UK.

 

To learn more about Dr. Tavaré’s research, visit his profile page.

 

 

Discussion and Q&A

Moderated by Harold Varmus, MD
Discussion and Q&A will take place after each speaker presents.
These meetings are held on the first Tuesday of each month and are intended for principal investigators in the New York region and their trainees.
Any questions on this event, contact events@nygenome.org.

 

 

  • +
    FIVE POINTS
    Five Points lecture series bring leading scientists from around the world for an in-depth discussion of their work with students, researchers and clinicians from the New York Genome Center, its member institutions, and others in the medical/scientific community. While Five Points lectures are free and open to the general public, these lectures are most beneficial to scientists, clinicians and researchers who wish to accelerate their research through the use of DNA sequencing technology and bioinformatics. Five Points lectures often frame five or so key points, in a nod to the series’ name — followed by 15 minutes of Q&A, and 30 minutes of networking over hors d’oeuvres and cocktails. These afternoon events are held in the Center’s state-of-the-art ground-floor auditorium starting at 4 pm.

  • +
    EVENING TALKS
    The New York Genome Center’s Evening Talks events feature distinguished experts from around the world sharing genomic insights and research. They are intended to showcase and explain high science to the non-scientific community. Speakers present the latest research findings and explain its implication for helping improve clinical care for a wide array of serious diseases. The lecture is followed by a lively question-and-answer session and a post-event reception of hors d’oeuvres and cocktails. These popular free public events are held in the Center’s state-of-the-art ground-floor auditorium starting at 6:30 pm. The Evening Talks Series is sponsored by The New York Community Trust – Pyewacket Fund.